US 11639355
Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors
granted A61PA61P31/04A61P31/12
Quick answer
US patent 11639355 (Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors) held by Medshine Discovery Inc. expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P31/04, A61P31/12, A61P35/00, A61P35/02